Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubicin via inducing cofilin oxidation-mediated mitochondrial fission and apoptosis.

MLA

Shen, Li-Wen, et al. “Cepharanthine Sensitizes Human Triple Negative Breast Cancer Cells to Chemotherapeutic Agent Epirubicin via Inducing Cofilin Oxidation-Mediated Mitochondrial Fission and Apoptosis.” Acta Pharmacologica Sinica, vol. 43, no. 1, Jan. 2022, pp. 177–93. EBSCOhost, https://doi.org/10.1038/s41401-021-00715-3.

APA

Shen, L.-W., Jiang, X.-X., Li, Z.-Q., Li, J., Wang, M., Jia, G.-F., Ding, X., Lei, L., Gong, Q.-H., & Gao, N. (2022). Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubicin via inducing cofilin oxidation-mediated mitochondrial fission and apoptosis. Acta Pharmacologica Sinica, 43(1), 177–193. https://doi.org/10.1038/s41401-021-00715-3

Chicago

Shen, Li-Wen, Xiu-Xing Jiang, Zhi-Qiang Li, Jie Li, Mei Wang, Guan-Fei Jia, Xin Ding, Ling Lei, Qi-Hai Gong, and Ning Gao. 2022. “Cepharanthine Sensitizes Human Triple Negative Breast Cancer Cells to Chemotherapeutic Agent Epirubicin via Inducing Cofilin Oxidation-Mediated Mitochondrial Fission and Apoptosis.” Acta Pharmacologica Sinica 43 (1): 177–93. doi:10.1038/s41401-021-00715-3.